Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes Mellitus
We compared the cardiovascular diseases (CVD) and risk factors in patients with stage 3–5 chronic kidney disease (CKD) and those with diabetes mellitus by analyzing the MAGNET study data of residents in northern Taiwan. The reimbursement of lipid-lowering therapy was also examined. Of the 1607 parti...
Main Authors: | Ta-Chuan Hung, Cheng-Huang Su, Yih-Jer Wu, Chung-Lieh Hung, Hung-I. Yeh, Li-Yu Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taiwan Society of Geriatric Emergency and Critical Medicine (TSGECM)
2017-03-01
|
Series: | International Journal of Gerontology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873959817300029 |
Similar Items
-
Lipid Abnormalities in Patient With Chronic Kidney Disease: A Cross-Sectional Study
by: Rajendra Mani Giri, et al.
Published: (2022-08-01) -
Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus
by: Lessey G, et al.
Published: (2019-08-01) -
Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease
by: Rupinder Kaur, et al.
Published: (2023-10-01) -
Association between aspirin use and cardiovascular outcomes in ALLHAT participants with and without chronic kidney disease: A post hoc analysis
by: Niraj Desai, et al.
Published: (2021-02-01) -
Oxidative Stress and Lipid Dysregulation in Lipid Droplets: A Connection to Chronic Kidney Disease Revealed in Human Kidney Cells
by: Zhen Chen, et al.
Published: (2022-07-01)